[go: up one dir, main page]

NO982711D0 - Antineoplastiske peptider - Google Patents

Antineoplastiske peptider

Info

Publication number
NO982711D0
NO982711D0 NO982711A NO982711A NO982711D0 NO 982711 D0 NO982711 D0 NO 982711D0 NO 982711 A NO982711 A NO 982711A NO 982711 A NO982711 A NO 982711A NO 982711 D0 NO982711 D0 NO 982711D0
Authority
NO
Norway
Prior art keywords
antineoplastic peptides
antineoplastic
peptides
Prior art date
Application number
NO982711A
Other languages
English (en)
Other versions
NO982711L (no
NO319273B1 (no
Inventor
Wilhelm Amberg
Teresa Barlozzari
Harald Bernard
Ernst Buschmann
Andreas Haupt
Hans-Guenther Hege
Bernd Janssen
Andreas Kling
Helmut Lietz
Kurt Ritter
Martina Ullrich
Juergen Weymann
Thomas Zierke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO982711L publication Critical patent/NO982711L/no
Publication of NO982711D0 publication Critical patent/NO982711D0/no
Publication of NO319273B1 publication Critical patent/NO319273B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19982711A 1995-12-15 1998-06-12 Antineoplastiske peptider, fremgangsmate for fremstilling og anvendelse derav. NO319273B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57342295A 1995-12-15 1995-12-15
PCT/EP1996/005518 WO1997022621A2 (en) 1995-12-15 1996-12-11 Antineoplastic peptides

Publications (3)

Publication Number Publication Date
NO982711L NO982711L (no) 1998-06-12
NO982711D0 true NO982711D0 (no) 1998-06-12
NO319273B1 NO319273B1 (no) 2005-07-11

Family

ID=24291935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982711A NO319273B1 (no) 1995-12-15 1998-06-12 Antineoplastiske peptider, fremgangsmate for fremstilling og anvendelse derav.

Country Status (30)

Country Link
EP (2) EP0866800B1 (no)
JP (1) JP3939354B2 (no)
KR (1) KR100463739B1 (no)
CN (1) CN1127514C (no)
AR (1) AR004382A1 (no)
AT (2) ATE277076T1 (no)
AU (2) AU731458B2 (no)
BG (1) BG64563B1 (no)
BR (1) BR9611987A (no)
CA (1) CA2237721C (no)
CO (1) CO4750840A1 (no)
CZ (1) CZ296908B6 (no)
DE (2) DE69638206D1 (no)
DK (1) DK0866800T3 (no)
ES (1) ES2229287T3 (no)
HR (1) HRP960585A2 (no)
HU (1) HU228275B1 (no)
IL (2) IL124342A (no)
MX (1) MX9803953A (no)
MY (1) MY114327A (no)
NO (1) NO319273B1 (no)
NZ (1) NZ324691A (no)
PL (1) PL186721B1 (no)
PT (1) PT866800E (no)
RU (1) RU2182911C2 (no)
SK (1) SK285286B6 (no)
TR (1) TR199801102T2 (no)
TW (1) TW474946B (no)
WO (1) WO1997022621A2 (no)
ZA (1) ZA9610510B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143721A (en) 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
JP2002538151A (ja) 1999-03-02 2002-11-12 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド カテプシンの可逆的インヒビターとして有用な化合物
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879276A (en) * 1983-12-19 1989-11-07 Uniroyal Chemical Ltd./Uniroyal Chemical Ltee Method for reducing serum uric acid levels
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
CZ292612B6 (cs) * 1992-05-20 2003-11-12 Abbott Gmbh & Co. Kg Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu
RU2132334C1 (ru) * 1992-12-16 1999-06-27 Басф Акциенгезельшафт Аналог долостатина
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof

Also Published As

Publication number Publication date
PL186721B1 (pl) 2004-02-27
PT866800E (pt) 2005-01-31
EP0866800A2 (en) 1998-09-30
ES2229287T3 (es) 2005-04-16
NO982711L (no) 1998-06-12
IL124342A (en) 2005-06-19
AU731458B2 (en) 2001-03-29
ATE471944T1 (de) 2010-07-15
HUP0000172A3 (en) 2000-09-28
BR9611987A (pt) 1999-02-17
DK0866800T3 (da) 2005-01-17
SK76798A3 (en) 1999-02-11
CN1127514C (zh) 2003-11-12
PL327175A1 (en) 1998-11-23
IL166853A (en) 2013-03-24
CZ184698A3 (cs) 1998-09-16
CA2237721A1 (en) 1997-06-26
AR004382A1 (es) 1998-11-04
NO319273B1 (no) 2005-07-11
BG64563B1 (bg) 2005-07-29
DE69638206D1 (de) 2010-08-05
SK285286B6 (sk) 2006-10-05
EP1593686A1 (en) 2005-11-09
WO1997022621A2 (en) 1997-06-26
ZA9610510B (en) 1998-06-15
HRP960585A2 (en) 1998-02-28
MY114327A (en) 2002-09-30
WO1997022621A3 (en) 1998-02-26
RU2182911C2 (ru) 2002-05-27
BG102479A (en) 1999-06-30
HU228275B1 (en) 2013-02-28
IL124342A0 (en) 1998-12-06
TR199801102T2 (xx) 1998-12-21
AU1192597A (en) 1997-07-14
EP1593686B1 (en) 2010-06-23
JP2000502092A (ja) 2000-02-22
CZ296908B6 (cs) 2006-07-12
TW474946B (en) 2002-02-01
AU2004220772A1 (en) 2004-11-11
ATE277076T1 (de) 2004-10-15
MX9803953A (es) 1998-09-30
CA2237721C (en) 2008-01-29
DE69633457T2 (de) 2005-09-22
AU2004220772B2 (en) 2008-06-12
KR20000064400A (ko) 2000-11-06
DE69633457D1 (de) 2004-10-28
CO4750840A1 (es) 1999-03-31
JP3939354B2 (ja) 2007-07-04
EP0866800B1 (en) 2004-09-22
CN1204342A (zh) 1999-01-06
HUP0000172A2 (en) 2000-07-28
KR100463739B1 (ko) 2005-02-28
NZ324691A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
DE69609678D1 (de) Synchronisiervorrichtung-Kupplung-Anordnung
DE69622196D1 (de) Motorträgeranordnung
DK0825860T3 (da) Præpart
ATA135896A (de) Skibob
BR9508433A (pt) Peptídeos
DK0760210T3 (da) Nultids-klemmeindretning
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
ATE198470T1 (de) Alkenyl-benzoylguanidine
DK0866800T3 (da) Antineoplastiske peptider
NO981051D0 (no) Peptidderivater
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
KR970013941U (ko) 납골단지
BR1100812A (pt) Peptìdeo
SE9504467D0 (sv) Peptide
BR7500363U (pt) Formulário
KR960030307U (ko) 다시
NO951804D0 (no) Turnus-oversiktsanordning
BR7500809U (pt) Tele-negocios
BR7500192U (pt) Parasitofiltro
BR7500437U (pt) Girolight
BR7500703U (pt) Rodopratic
BR7500040U (pt) Raquet mastit
BR7500825U (pt) Chutegol

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ABBVIE DEUTSCHLAND GMBH & CO AG, DE

MM1K Lapsed by not paying the annual fees